🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Reasons such as sleep disorders, depression, decreased independence in dail...
Status
Not Yet Recruiting
Location
Sivas Cumhuriyet University
Start Date
2026-02-19
Trial ID
NCT06749340
Treatments Being Tested
The aim of this study is to develop and conduct psychometric testing of a n...
Status
Completed
Location
Elementary school
Start Date
2023-02-01
Trial ID
NCT06466252
Treatments Being Tested
Schizophrenia affects about 1% of the world's population. According to the ...
Status
Completed
Location
Centre Hospitalier Esquirol
Start Date
2018-07-03
Trial ID
NCT03801551
Population-based and clinical studies indicate that a substantial proportio...
Status
Recruiting
Location
Traumaambulanz, Universitätsklinikum Aachen
Start Date
2025-12-15
Trial ID
NCT07368166
In France today, it is estimated that one in every 850 people aged between ...
Status
Recruiting
Location
CHU Angers
Start Date
2025-03-18
Trial ID
NCT07117058
This study aims to evaluate the psychometric properties of the Compliance o...
Status
Completed
Location
Hacettepe University
Start Date
2020-06-01
Trial ID
NCT04813393
Treatments Being Tested
Secondary prevention of prostate cancer (PCa) is not standardized and high-...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-02-01
Trial ID
NCT05681416
Treatments Being Tested
Minimal hepatic encephalopathy (MHE) is a covert form of hepatic encephalop...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-12-01
Trial ID
NCT07272707
Treatments Being Tested
Obesity is a global epidemic and a major contributor to some of the leading...
Status
Completed
Location
Istituto Auxologico Italiano
Start Date
2021-03-15
Trial ID
NCT05804292
Treatments Being Tested
AVE1625 is a new potent and selective cannabinoid 1 (CB1) antagonist in cli...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2007-02
Trial ID
NCT00439634